Structure-based de novo design of novel inhibitors of the MDM2-p53 interaction

被引：0

作者：

Sun, Daqing ^{[1
]}

Rew, Yosup ^{[1
]}

De Turiso, Felix Gonzalez Lopez ^{[1
]}

Bartberger, Michael D. ^{[3
]}

Beck, Hilary P. ^{[1
]}

Canon, Jude ^{[4
]}

Chen, Ada ^{[1
]}

Chow, David ^{[1
]}

Deignan, Jeffrey ^{[1
]}

Fox, Brian M. ^{[1
]}

Huang, Xin ^{[5
]}

Jiang, Min ^{[2
]}

Jiao, Xianyun ^{[1
]}

Jin, Lixia ^{[2
]}

Kopecky, David J. ^{[1
]}

Li, Yihong ^{[1
]}

Lo, Mei-Chu ^{[1
]}

Long, Alexander M. ^{[5
]}

Michelsen, Klaus ^{[3
]}

Oliner, Jonathan D. ^{[4
]}

Osgood, Tao ^{[4
]}

Saiki, Anne Y. ^{[4
]}

Schneider, Steve ^{[5
]}

Yakowec, Peter ^{[5
]}

Yan, Xuelei ^{[1
]}

Ye, Qiuping ^{[2
]}

Yu, Dongyin ^{[4
]}

Zhao, Xiaoning ^{[1
]}

Zhou, Jing ^{[1
]}

Olson, Steven H. ^{[1
]}

Medina, Julio C. ^{[1
]}

机构：

[1] Amgen Inc, Therapeut Discovery, San Francisco, CA 94080 USA

[2] Amgen Inc, Pharmacokinet & Drug Metab, San Francisco, CA 94080 USA

[3] Amgen Inc, Therapeut Discovery, Thousand Oaks, CA 91320 USA

[4] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, Therapeut Discovery, Cambridge, MA 02142 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 50 条

[21] Structural details on mdm2-p53 interaction
Chi, SW
Lee, SH
Kim, DH
Ahn, MJ
Kim, JS
Woo, JY
Torizawa, T
Kainosho, M
Han, KH
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (46) : 38795 - 38802
[22] Rational Design and Binding Mode Duality of MDM2-p53 Inhibitors
de Turiso, Felix Gonzalez-Lopez
Sun, Daqing
Rew, Yosup
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Correll, Tiffany L.
Huang, Xin
Julian, Lisa D.
Kayser, Frank
Lo, Mei-Chu
Long, Alexander M.
McMinn, Dustin
Oliner, Jonathan D.
Osgood, Tao
Powers, Jay P.
Saiki, Anne Y.
Schneider, Steve
Shaffer, Paul
Xiao, Shou-Hua
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Medina, Julio C.
Olson, Steven H.
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (10) : 4053 - 4070
[23] Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure- based virtual screening
Atatreh, Noor
Ghattas, Mohammad A.
Bardaweel, Sanaa K.
Al Rawashdeh, Sara
Al Sorkhy, Mohammad
DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3741 - 3752
[24] Rational design and binding mode duality of MDM2-p53 inhibitors
de Turiso, Felix Gonzalez-Lopez
Sun, Daqing
Rew, Yosup
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Correll, Tiffanny L.
Huang, Xin
Julian, Lisa D.
Kayser, Frank
Lo, Mei-Chu
Long, Alexander M.
McMinn, Dustin
Oliner, Jonathan D.
Osgood, Tao
Powers, Jay P.
Saiki, Anne Y.
Schneider, Steve
Shaffer, Paul
Xiao, Shou-Hua
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Medina, Julio C.
Olson, Steven H.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[25] The Structure-Based Design of Mdm2/Mdmx-p53 Inhibitors Gets Serious
Popowicz, Grzegorz M.
Doemling, Alexander
Holak, Tad A.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (12) : 2680 - 2688
[26] Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument
Furet, Pascal
Masuya, Keiichi
Kallen, Joerg
Stachyra-Valat, Therese
Ruetz, Stephan
Guagnano, Vito
Holzer, Philipp
Mah, Robert
Stutz, Stefan
Vaupel, Andrea
Chene, Patrick
Jeay, Sebastien
Schlapbach, Achim
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) : 4837 - 4841
[27] Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer
Bhatia, Neha
Khator, Rakesh
Kulkarni, Swanand
Singh, Yogesh
Kumar, Pradeep
Thareja, Suresh
CURRENT MEDICINAL CHEMISTRY, 2023, 30 (32) : 3668 - 3701
[28] Computational analysis of spiro-oxindole inhibitors of the MDM2-p53 interaction: insights and selection of novel inhibitors
Huang, Wei
Cai, Lulu
Chen, Can
Xie, Xin
Zhao, Qiong
Zhao, Xing
Zhou, Hong-yun
Han, Bo
Peng, Cheng
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2016, 34 (02): : 341 - 351
[29] MEDI 92-Discovery of potent small molecule inhibitors of the MDM2-p53 interaction through pharmacophore-based and structure-based database screening
Lu, Yipin
Nilolovska-Coleska, Zaneta
Qiu, Su
Kumar, Sanjeev
Gao, Wei
Fang, Xueliang
Qin, Dongguang
Wang, Shaomeng
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[30] Inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.
Hardcastle, IR
Ahmed, SU
Barrett, PA
Endicott, JA
Golding, BT
Griffin, RJ
Gruber, J
Hutton, C
Kemp, SJ
Lunec, J
Noble, ME
Riedinger, C
Smyth, LA
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9053S - 9054S

← 1 2 3 4 5 →